LLP and Moscone.

The recall Files Consumer Fraud Class Action Against Advanced Medical Optics for False Advertising Contact Lens Solution – announced Lieff Cabraser Heimann & Bernstein, LLP and Moscone, Emblidge & Quadra that Southern California-based Advanced Medical Optics was a defendant in a consumer fraud and false advertising class action named. The case of brought the v. Advanced Medical Optics, was submitted today. In California State Superior Court in Orange County Maria Ruiz brought the complaint on their behalf and on behalf of all California consumers, AMO Complete Easy Rub Multipurpose Solution Formula , a contact lens cleaning and disinfecting product bought.

The recall followed a report from the Centers for Disease Control linking Complete MoisturePlus to an outbreak of severe corneal infections, such as Acanthamoeba keratitis known. And misleading information housed with hundreds of products liability cases and claims by consumers who developed the sight of disease after using Complete MoisturePlus. – AMO advertising for Easy Rub formula as new and unique when the product is on the market in the market in 2007. However, Ruiz throws appeal Easy Rub actually contains an old formula which AMO use for years so-called so-called private label solution for retail giant Costco under its Kirkland Signature brand. The Kirkland product is significantly cheaper than Easy Rub even though the formulas are identical.The American Lung Association markers World TB Day, March by urging Congress to sustain our efforts at global leading position in eradicating this infectious diseases. Disease 9 million people become ill TB of, and almost 2 million to die. TB are anticipated that kill additional millions, in the next decade.

However, the most effective treatment form, in terms of duration and number of cycles, is still unclear.. ** fourteen CHOP arm of chemotherapy cyclophosphamide, doxorubicin, vincristine, prednisolone, and with two -week intervals.

Since more than 25 years, the CHOP was the standard care for aggressive lymphomas. But, 2000, showed the German Groupe de L’Etude de L Lymphomes of adults that the addition of monoclonal antibody – CD20 antibody rituximab to eight cycles from 3 – weekly CHOP chemo improved results for the patients with DLBCL. 1 percent of improvement had the German High-Grade Non-Hodgkin’s Lymphoma Study Group by decreasing the the interval chemotherapy for six cycles CHOP chemotherapy alone up to 2 weeks to 2 weeks . Both approaches improved earnings of the elderly patients without an increase side effects.